Peter Orio, DO
Radiation Oncology · Boston, MANPI 1174639736
Payments from drug & device makers
Across 432 payments — averaging $4301.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teleflex LLC$1.1M
- Palette Life Sciences, Inc.$409K
- Theragenics Corporation$213K
- Boston Scientific$37K
- Accuray Incorporated$20K
- GT Medical Technologies, Inc$19K
- plus $34K from 12 others
What the payments were for
- Consulting fees$1,450,22179%
- Speaking & faculty fees$269,61515%
- Travel & lodging$68,0184%
- Food & beverage$13,4361%
- Education$5,0000%
- Gifts$1020%
- Entertainment$280%
- Ownership interest$14,2291%
- Other$21,9231%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teleflex LLC | 226 | $1,126,551 |
| Palette Life Sciences, Inc. | 54 | $408,866 |
| Theragenics Corporation | 37 | $212,967 |
| Boston Scientific | 18 | $37,230 |
| Accuray Incorporated | 21 | $20,185 |
| GT Medical Technologies, Inc | 12 | $19,028 |
| Janssen Scientific Affairs, LLC | 15 | $13,211 |
| Augmenix, Inc. | 1 | $8,000 |
| Nucletron Operations B.v. | 5 | $4,031 |
| Isoray, Inc | 19 | $2,512 |
| Blue Earth Diagnostics | 7 | $2,509 |
| Varian Medical Systems, Inc. | 2 | $2,089 |
| Elekta, Inc. | 6 | $361 |
| Arrow International, Inc. | 4 | $228 |
| Bioprotect Medical, Inc. | 2 | $223 |
| Myriad Genetic Laboratories, Inc. | 1 | $200 |
| Bard Peripheral Vascular, Inc. | 1 | $127 |
| Astellas Pharma US Inc | 1 | $93 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Barrigel$541,502
- GENERAL - THERAPIES$32,937
- CyberKnife System$18,833
- TomoTherapy System$14,539
- Erleada$12,769
- SPACEOAR$8,000
- FLEXITRON HDR$3,398
- Esteya$3,398
- MICROSELECTRON DIGITAL$3,398
- GammaTile$3,054
- POSLUMA$2,311
- Brachytherapy Source$2,026
- BrachyVision$2,000
- UroLift$1,900
- ELEKTA MEDICAL LINEAR ACCELERATOR$758
- SpaceOAR VUE System - 10mL$450
- Prolaris$200
- BIOPROTECT BALLOON IMPLANT SYSTEM$131
- Model 200 TheraSeed Palladium-103 in ReadyLink$127
- GENERAL ONCOLOGY$127
How this compares
$1,858,414 in reported general payments places this provider in the 95th percentile of 200 radiation oncology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 22 | $323 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Boston
- Alice HoBoston$6.3M
- Paul NguyenBoston$5.4M
- Daphne Haas-KoganBoston$5.3M
- Martin KingBoston$3.9M
- Anthony DamicoBoston$2.9M
- Theodore HongBoston$2.9M
- Jonathan SchoenfeldBoston$1.7M
- Brian AlexanderBoston$610K
- Jennifer WoBoston$506K
- Jonathan LeemanBoston$487K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.